New Fortress Energy
NFE
SilverCrest Metals
SILV
Hutchmed (China)
HCM
Dorian LPG
LPG
Precision Drilling
PDS
US Stock MarketDetailed Quotes
PBM Psyence Biomedical
- 2.080
- -0.030-1.42%
Close Jan 2 16:00 ET
- 2.170
- +0.090+4.33%
Post 20:01 ET
7.13MMarket Cap-0.01P/E (TTM)
2.270High2.060Low186.16KVolume2.060Open2.110Pre Close401.56KTurnover6.10%Turnover RatioLossP/E (Static)3.43MShares945.15052wk High-0.65P/B6.35MFloat Cap1.51052wk Low--Dividend TTM3.05MShs Float1091.250Historical High--Div YieldTTM9.95%Amplitude1.510Historical Low2.157Avg Price1Lot Size
About Psyence Biomedical Company
Psyence Biomedical Ltd. is a life science biotechnology company. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company was founded on February 25, 2021 and is headquartered in Toronto, Canada.
Company Profile
SymbolPBM
Company NamePsyence Biomedical
Listing DateDec 10, 2021
Founded2021
CEODr. Neil Maresky
MarketNASDAQ
Employees10
Fiscal Year Ends03-31
Address121 Richmond Street West,Penthouse Suite 1300
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM5H 2K1
Phone1-416-346-7764
Websitehttp://psyence.com
Company Executives
- Name
- Position
- Salary
- Dr. Neil Maresky
- Chief Executive Officer and Director
- 356.69K
- Jody Aufrichtig
- Chairman of the Board and Strategic Business Development Officer
- 185.00K
- Christopher Bull
- Independent Director
- --
- Dr. Seth Feuerstein
- Independent Director
- --
- Marc Gregory Balkin
- Independent Director
- --
- Warwick Corden-Lloyd
- Chief Financial Officer
- 123.33K